October 2023 Subtopic 4 ‘VAXinS’ of Inno4Vac is developing a modular one-stop computational platform for in silico modelling of vaccine...

04 October 2023 The recent 13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (CLOSTPATH), in Banff,...

We are pleased to share the 1st Inno4Vac newsletter where you will find a summary of the communication efforts by EVI over the last few...

August 2023 Inno4Vac announces the nomination of the independent Scientific and Ethics Advisory Committee (SEAC) of the Inno4Vac project....

The 2nd Inno4Vac ST3 (MERMAID) Regulatory stakeholder meeting was held June 27-28 and hosted by the Paul-Ehrlich-Institut in Langen, GE.

16 May 2023 The subtopic1, VAXPRED, dedicated to build an open access and cloud-based platform to predict vaccine efficacy using...

16 November 2022 To advance the ambitious programme of Inno4Vac, which aims to harness the latest advances in immunology and disease...

14 December 2021 The subtopic 2, CHIMICHURRI, dedicated to the development of new and improved Control Human Infection Models (CHIM) for...

29 September 2021 The kick-off meeting of Inno4Vac, a project that targets faster vaccine development and manufacture, by harnessing the...

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 38.5 million to support Inno4Vac, an innovative...